239 related articles for article (PubMed ID: 19657105)
1. Transcranial brain sonography findings predict disease progression in multiple sclerosis.
Walter U; Wagner S; Horowski S; Benecke R; Zettl UK
Neurology; 2009 Sep; 73(13):1010-7. PubMed ID: 19657105
[TBL] [Abstract][Full Text] [Related]
2. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.
Walter U; Krolikowski K; Tarnacka B; Benecke R; Czlonkowska A; Dressler D
Neurology; 2005 May; 64(10):1726-32. PubMed ID: 15911799
[TBL] [Abstract][Full Text] [Related]
3. Transcranial sonography of subcortical structures in patients with multiple sclerosis.
Puz P; Lasek-Bal A; Radecka P
Acta Neurol Scand; 2017 Jul; 136(1):24-30. PubMed ID: 27642106
[TBL] [Abstract][Full Text] [Related]
4. Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis.
Horowski S; Zettl UK; Benecke R; Walter U
J Neurol; 2011 Feb; 258(2):195-202. PubMed ID: 20740288
[TBL] [Abstract][Full Text] [Related]
5. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
[TBL] [Abstract][Full Text] [Related]
6. Diameter assessment of the third ventricle with transcranial sonography in patients with multiple sclerosis.
Schminke U; Lorenz L; Kirsch M; von Sarnowski B; Khaw AV; Kessler C; Dressel A
J Neuroimaging; 2010 Jan; 20(1):53-7. PubMed ID: 19021825
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
8. T2 lesions and rate of progression of disability in multiple sclerosis.
Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
[TBL] [Abstract][Full Text] [Related]
9. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.
Berg D; Becker G; Zeiler B; Tucha O; Hofmann E; Preier M; Benz P; Jost W; Reiners K; Lange KW
Neurology; 1999 Sep; 53(5):1026-31. PubMed ID: 10496262
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
11. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.
Zivadinov R; Schirda C; Dwyer MG; Haacke ME; Weinstock-Guttman B; Menegatti E; Heininen-Brown M; Magnano C; Malagoni AM; Wack DS; Hojnacki D; Kennedy C; Carl E; Bergsland N; Hussein S; Poloni G; Bartolomei I; Salvi F; Zamboni P
Int Angiol; 2010 Apr; 29(2):158-75. PubMed ID: 20351672
[TBL] [Abstract][Full Text] [Related]
12. Quantitative transcranial sonography in Wilson's disease and healthy controls: Cut-off values and functional correlates.
Tribl GG; Trindade MC; Almeida KJ; Alves RC; de Andrade DC; Fonoff ET; Machado AA; Teixeira MJ; Barbosa ER; Bor-Seng-Shu E
J Neurol Sci; 2018 Feb; 385():69-74. PubMed ID: 29406916
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
Walter U; Wittstock M; Benecke R; Dressler D
J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
[TBL] [Abstract][Full Text] [Related]
14. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
[TBL] [Abstract][Full Text] [Related]
15. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.
Mašková J; Školoudík D; Burgetová A; Fiala O; Brůha R; Záhoráková D; Serranová T; Slovák M; Ulmanová O; Růžička E; Dušek P
Parkinsonism Relat Disord; 2016 Jul; 28():87-93. PubMed ID: 27147115
[TBL] [Abstract][Full Text] [Related]
17. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
[TBL] [Abstract][Full Text] [Related]
18. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
[TBL] [Abstract][Full Text] [Related]
19. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
